Originally published on September 17, 2013.Dr. Swoboda was awarded funding by Cure SMA for one of four Clinical Care focused projects. The project is being conducted at the University of Utah. This award ...
Originally published on October 1, 2013.Dr. Timothy Lotze was awarded funding by Cure SMA for one of four new Clinical Care focused projects. The project is being conducted at Texas Children’s Hospital at ...
Originally published on September 25, 2013.Dr. Matthew Halanski was awarded funding by Cure SMA for one of four Clinical Care focused projects. The project is being conducted at the University of Wisconsin. This ...
Originally published on December 30, 2013. Cure SMA is proud to have contributed funding to the research published in the following journal articles in 2013. Cure SMA has invested over $55 Million in ...
Originally published on October 24, 2013.Cure SMA invests in four research areas: Basic Research, Drug Discovery, Clinical Research, and Care Research. Cure SMA has invested over $55 Million in research since 1984, with ...
Originally published on November 5, 2013.Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed its efficacy ...
Originally published on September 19, 2013.Isis Pharmaceuticals, Inc. announced today that follow-up preliminary data from a single dose, open-label Phase 1 study of ISIS-SMNRx in children with spinal muscular atrophy (SMA), show that ...
Originally published on September 4, 2013. Reaching the first milestone was triggered by completion of specific program activities and coincides with the successful completion of all transition obligations to Pfizer by Repligen. Click ...
Originally published on January 22, 2014. PTC announces that its SMA drug program, partnered with Roche, begins Phase I Safety Trials in healthy, adult volunteers. This brings the total number of SMA programs ...
Originally published on February 20, 2014.Cure SMA is proud to announce our new basic research funding for 2014. We are leading the way to a world without SMA by advancing a comprehensive research ...
Originally published on February 27, 2014.Cure SMA is leading the way to a world without SMA by advancing a comprehensive research program, of which basic research is a key component. Cure SMA has ...
Originally published on March 4, 2014.Cure SMA is leading the way to a world without SMA by advancing a comprehensive research program, of which basic research is a key component. Cure SMA has ...
